JAC Advance Access originally published online on July 1, 2006
Journal of Antimicrobial Chemotherapy 2006 58(2):256-265; doi:10.1093/jac/dkl224
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reviews |
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
1 Department of Medical Microbiology, Old Medical School, Leeds General Infirmary Great George Street, Leeds LS1 2EX, UK 2 Bristol Centre for Antimicrobial Research & Evaluation, Department of Medical Microbiology, Southmead Hospital Westbury-on-Trym, Bristol BS10 5NB, UK
*Corresponding author. Tel: +44-117-959-5652; Fax: +44-117-959-3154; E-mail: alasdair.macgowan{at}nbt.nhs.uk
The pharmacokinetics of tetracyclines and glycylcyclines are described in three groups. Group 1, the oldest group, represented by tetracycline, oxytetracycline, chlortetracycline, demeclocycline, lymecycline, methacycline and rolitetracycline is characterized by poor absorption after food. Group 2, represented by doxycycline and minocycline, is more reliably absorbed orally, while group 3, represented by the glycylcycline tigecycline, is injectable only, with an improved antibacterial spectrum compared with the tetracyclines. Though incompletely understood, the pharmacodynamic properties of the tetracyclines and glycylcyclines are summarized.
Keywords: pharmacokinetics , pharmacodynamics , tetracyclines
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. P. MacGowan Tigecycline pharmacokinetic/pharmacodynamic update J. Antimicrob. Chemother., September 1, 2008; 62(suppl_1): i11 - i16. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sousa, A. Pozniak, and M. Boffito Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs J. Antimicrob. Chemother., August 18, 2008; (2008) dkn330v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Batty, A. S. F. Law, V. Stirling, and B. R. Moore Pharmacodynamics of Doxycycline in a Murine Malaria Model Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4477 - 4479. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kielian, N. Esen, S. Liu, N. K. Phulwani, M. M. Syed, N. Phillips, K. Nishina, A. L. Cheung, J. D. Schwartzman, and J. J. Ruhe Minocycline Modulates Neuroinflammation Independently of Its Antimicrobial Activity in Staphylococcus aureus-Induced Brain Abscess Am. J. Pathol., October 1, 2007; 171(4): 1199 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M Slover, K. A Rodvold, and L. H Danziger Tigecycline: A Novel Broad-Spectrum Antimicrobial Ann. Pharmacother., June 1, 2007; 41(6): 965 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Sader, M. J. Ferraro, L. B. Reller, P. C. Schreckenberger, J. M. Swenson, and R. N. Jones Reevaluation of Clinical and Laboratory Standards Institute Disk Diffusion Breakpoints for Tetracyclines for Testing Enterobacteriaceae J. Clin. Microbiol., May 1, 2007; 45(5): 1640 - 1643. [Abstract] [Full Text] [PDF] |
||||




